Khiron Life Sciences Corp. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was CAD 8.016 million compared to CAD 9.582 million a year ago. Net loss was CAD 24.038 million compared to CAD 36.377 million a year ago. Basic loss per share from continuing operations was CAD 0.2 compared to CAD 0.36 a year ago.